Earnings Scheduled For March 3 (MRVL, HNZ, KR, NOVL, ALTH, BIG, BRLI, ACU, CLDX, ADUS, ACCL, IRWD)

Marvell Technology Group Ltd (NASDAQ: MRVL) is projected to report its Q4 earnings at $0.42 per share on revenue of $925.64 million. H.J. Heinz Co (NYSE: HNZ) is estimated to post its FQ3 earnings at $0.81 per share on revenue of $2.71 billion. Kroger Company (NYSE: KR) is expected to report its Q4 EPS at $0.44 on revenue of $19.37 billion. Novell Inc (NASDAQ: NOVL) is estimated to report its FQ1 earnings at $0.07 per share on revenue of $199.00 million. Allos Therapeutics Inc (NASDAQ: ALTH) is expected to post a Q4 loss at $0.18 per share on revenue of $11.23 million. Big Lots Inc (NYSE: BIG) is projected to report its Q4 EPS at $1.38 on revenue of $1.52 billion. Bio-Reference Laboratories Inc (NASDAQ: BRLI) is expected to post its Q1 EPS at $0.17 on revenue of $119.12 million. Acme United Corporation (AMEX: ACU) is estimated to report its Q4 earnings at $0.14 per share on revenue of $14.59 million. Celldex Therapeutics Inc (NASDAQ: CLDX) is expected to post its Q4 EPS at $0.21 on revenue of $27.73 million. Addus HomeCare Corporation (NASDAQ: ADUS) is projected to post its Q4 EPS at $0.14 on revenue of $70.45 million. Accelrys Inc (NASDAQ: ACCL) is expected to post its quarterly EPS at $0.08 on revenue of $40.29 million. Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) is projected to report a Q4 loss at $0.15 per share on revenue of $9.46 million. Read more from Benzinga's Markets.